Atenção farmacêutica a um portador de diabetes : relato de caso

Abstract

Treatment of type 2 diabetes mellitus (DM) aims primarily to prevent its complications. Thus, the pharmaceutical care can be an essential tool for pharmacotherapeutic monitoring (PM) , since the diabetic patient needs to receive guidance that can reduce mortality and promote a better life quality. The present study aimed to perform a therapeutic monitoring a user with DM who conducts monitoring on health services in primary care in the southeastern area of the city of Teresina, Piauí. For both the methodology proposed by Dáder Method for pharmacotherapeutic monitoring was used. The user had their pharmacotherapy evaluated for detection of possible drug-related problems (DRPs) and preparation of pharmaceutical interventions to address them. Given the results, it was found that interventions are achieving 90% effectiveness, and its were based on verbal directions to the user, intervention with physicians and preparation of newsletters, as well as guidance in health education, in order to avoid the complications of diabetes. Despite the difficulties presented by this case study was possible to measure the importance of PM in order to avoid the occurrence of DRPs and consequently improve the life quality of patients with DM.